Details for New Drug Application (NDA): 211608
✉ Email this page to a colleague
The generic ingredient in CYCLOPHOSPHAMIDE is cyclophosphamide. There are nineteen drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the cyclophosphamide profile page.
Summary for 211608
Tradename: | CYCLOPHOSPHAMIDE |
Applicant: | Cipla |
Ingredient: | cyclophosphamide |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 211608
Mechanism of Action | Alkylating Activity |
Medical Subject Heading (MeSH) Categories for 211608
Suppliers and Packaging for NDA: 211608
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CYCLOPHOSPHAMIDE | cyclophosphamide | CAPSULE;ORAL | 211608 | ANDA | Cipla USA Inc. | 69097-516 | 69097-516-07 | 100 CAPSULE in 1 BOTTLE (69097-516-07) |
CYCLOPHOSPHAMIDE | cyclophosphamide | CAPSULE;ORAL | 211608 | ANDA | Cipla USA Inc. | 69097-517 | 69097-517-07 | 100 CAPSULE in 1 BOTTLE (69097-517-07) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 25MG | ||||
Approval Date: | Jan 18, 2019 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 50MG | ||||
Approval Date: | Jan 18, 2019 | TE: | AB | RLD: | No |
Complete Access Available with Subscription